We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$308M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$188M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$172M
4
PSA icon
Public Storage
PSA
+$47.9M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46.9M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$53.7M
2
MCD icon
McDonald's
MCD
+$46.3M
3
SO icon
Southern Company
SO
+$33.8M
4
HEWJ icon
iShares Currency Hedged MSCI Japan ETF
HEWJ
+$26.3M
5
ETP
Energy Transfer Partners L.p.
ETP
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
1426
Nektar Therapeutics
NKTR
$2.47B
$2.48M 0.01%
8,463
+679
+9% +$196K
KWR icon
1427
Quaker Houghton
KWR
$2.94B
$2.48M 0.01%
17,080
+958
+6% +$135K
TFCF
1428
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$2.48M 0.01%
89,036
+3,234
+4% +$91.7K
ADC icon
1429
Agree Realty
ADC
$9.46B
$2.47M 0.01%
53,878
-5,094
-9% -$242K
SYNH
1430
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.47M 0.01%
42,221
+928
+2% +$48.2K
JMF
1431
DELISTED
NUVEEN ENERGY MLP TOTAL RETURN FUND
JMF
$2.46M 0.01%
186,222
+8,125
+5% +$107K
XENT
1432
DELISTED
Intersect ENT, Inc
XENT
$2.45M 0.01%
87,757
+1,744
+2% +$39.5K
SHYG icon
1433
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$2.45M 0.01%
51,185
+33,070
+183% +$1.58M
DFNL icon
1434
Davis Select Financial ETF
DFNL
$491M
$2.45M 0.01%
+113,207
New +$2.37M
PID icon
1435
Invesco International Dividend Achievers ETF
PID
$917M
$2.44M 0.01%
158,719
+26,982
+20% +$409K
OKS
1436
DELISTED
Oneok Partners LP
OKS
$2.44M 0.01%
47,697
-1,865
-4% -$94.5K
KYE
1437
DELISTED
Kayne Anderson Energy
KYE
$2.43M 0.01%
218,832
+10,269
+5% +$118K
MDU icon
1438
MDU Resources
MDU
$4.18B
$2.43M 0.01%
244,164
+10,977
+5% +$112K
CADE
1439
DELISTED
Cadence Bank
CADE
$2.43M 0.01%
79,698
-12,941
-14% -$388K
FLXN
1440
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2.43M 0.01%
120,245
+56,835
+90% +$1.18M
CM icon
1441
Canadian Imperial Bank of Commerce
CM
$108B
$2.43M 0.01%
59,770
+11,614
+24% +$469K
IX icon
1442
ORIX
IX
$45.1B
$2.42M 0.01%
155,310
+14,015
+10% +$219K
CRI icon
1443
Carter's
CRI
$1.47B
$2.41M 0.01%
27,109
-94
-0.3% -$8.27K
EWP icon
1444
iShares MSCI Spain ETF
EWP
$2.15B
$2.41M 0.01%
+73,262
New +$2.37M
ELLI
1445
DELISTED
Ellie Mae Inc
ELLI
$2.4M 0.01%
21,870
+631
+3% +$68.3K
IVZ icon
1446
Invesco
IVZ
$14.1B
$2.4M 0.01%
68,291
-30,550
-31% -$996K
WFM
1447
DELISTED
Whole Foods Market Inc
WFM
$2.4M 0.01%
56,937
-194,427
-77% -$7.08M
PBH icon
1448
Prestige Consumer Healthcare
PBH
$2.51B
$2.4M 0.01%
45,383
+13,717
+43% +$735K
GGZ
1449
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$127M
$2.4M 0.01%
193,857
+4,668
+2% +$55.6K
LVHB
1450
DELISTED
Innovator Lunt Low Vol/High Beta Tactical ETF
LVHB
$2.4M 0.01%
78,367
+9,750
+14% +$295K
56 57
58
59 60

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.